Log in to save to my catalogue

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safegua...

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safegua...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1bf355be0de745bc987455ce3536745a

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

About this item

Full title

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-06, Vol.11 (1), p.2713-14, Article 2713

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite their rapidly-expanding therapeutic potential, human pluripotent stem cell (hPSC)-derived cell therapies continue to have serious safety risks. Transplantation of hPSC-derived cell populations into preclinical models has generated teratomas (tumors arising from undifferentiated hPSCs), unwanted tissues, and other types of adverse events. Mi...

Alternative Titles

Full title

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1bf355be0de745bc987455ce3536745a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1bf355be0de745bc987455ce3536745a

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-16455-7

How to access this item